LIVE - Innovative Approaches in Lymphoma Diagnosis: Small Specimens, Big Impact

This activity is part of the 2025-2026 Cyto-econference Series. Registration to the series is required to obtain the access code. You can register for the series by clicking the link below.

 

Roberto Ruiz-Cordero, MD
Director of Cytopathology
University of Miami Hospital
Miami, Florida

 

This webinar addresses critical gaps in the use of FNA for evaluating lymphadenopathy, emphasizing its potential as a minimally invasive, cost-effective diagnostic tool with the ability to quickly triage patients. Despite its many advantages, diagnosing lymphoma through FNA presents challenges, particularly with paucicellular samples and the need for high-quality specimens and ancillary testing for accurate categorization using recent classification systems. The importance of a multidisciplinary approach and collaboration between cytopathologists and hematopathologists, for enhanced diagnostic accuracy and optimal patient care is emphasized. The goal of the webinar is to empower participants to be able to categorize patients into diagnostic groups with specific risks of malignancy that guide further management decisions rather than striving for definitive WHO/ICC diagnoses.

Target Audience

This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.

Learning Objectives

  • Effectively utilize fine-needle aspiration as a first-line diagnostic tool for lymphadenopathy, recognizing its strengths and limitations.
  • Identify and implement best practices for obtaining and handling high-quality FNA specimens to ensure accurate categorization and diagnosis.
  • Enhance diagnostic accuracy and patient management by incorporating ancillary testing results and fostering multidisciplinary collaboration between cytopathologists and hematopathologists, integrating their expertise in the evaluation of lymphoma from small biopsy specimens.
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 Participant
Course opens: 
02/16/2026
Course expires: 
02/23/2028
Cost:
$0.00

Presenter(s):
Roberto Ruiz-Cordero, MD

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.

The following individuals have reported financial relationships:
Christopher J. VandenBussche MD PhD: Ad hoc advisory board panel and Consultant – Roche

The following individuals have reported no relevant financial relationships:
Donna Armylagos, BA, CT(ASCP), Kristen Atkins, MD, Catherine Bammert, PhD, CT, MB(ASCP), CT(IAC), Christine Booth, MD, Bonnie Choy, MD, Amy Clayton, MD, Jacqueline Cuda, BS, SCT(ASCP), Fang Fan, MD, PhD, Beverly Haigler-Daly, BS, CT(ASCP), Michael Henry, MD, Zaibo Li, MD, PhD, Steven Long, MD, Lorena Marcano-Bonilla, MD, PhD, Erin McCarthy, MPH, CT(ASCP)IAC, Sean McNair, MPH, CT(ASCP). Rachelle Mendoza, Sara Monaco, MD, Michiya Nishino, MD, PhD, Judy Pang, MD, Melissa Randolph, BS, SCT(ASCP), Michelle Reid, MD, MSc, Sinchita Roy-Chowdhuri, MD, PhD, Divya Salibindla, MD, Momin Siddiqui, MD, FIAC, Madison Swaney, MD, Michael Thrall, MD, Vivian Weiss, MD, PhD, Ashley Zucker, MS, CT(ASCP)

The ASC staff associated with the development of content for this activity reported no relevant financial relationships.

Presenter:
The presenter has a conflict of interest or financial relationships to disclose.
Roberto Ruiz-Cordero, MD: Consultant, Stock options - Ruby Robotics

ACCREDITATION AND DESIGNATION STATEMENTS

Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

American Board of Pathology Continuing Certification (CC)
This product can help fulfill the CME requirements mandated by the American Board of Pathology Continuing Certification (CC) process.  Earn up to 2.0 Credit Hours.

Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians.  The CMLE credit hours meet the continuing education requirements for the ASCP Board of  Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Cytologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 Participant

Price

Cost:
$0.00
Please login or register to take this course.